{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:22:58Z","timestamp":1764937378423,"version":"3.41.2"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:italic>Frontiers<\/jats:italic> requested research on how a systems approach can explore the mechanisms of cardiovascular complications in Covid-19. The focus of this paper will thus be on these detailed mechanisms. It will elucidate the integrated pathogenic pathways based on an extensive review of literature. Many severe Covid-19 cases and deaths occur in patients with chronic cardiovascular comorbidities. To help understand all the mechanisms of this interaction, Covid-19 complications were integrated into a pre-existing systems-based coronary heart disease (CHD) model. Such a complete model could not be found in literature. A fully integrative view could be valuable in identifying new <jats:italic>pharmaceutical interventions<\/jats:italic>, help understand how <jats:italic>health factors<\/jats:italic> influence Covid-19 severity and give a fully integrated explanation for the Covid-19 <jats:italic>death spiral<\/jats:italic> phenomenon seen in some patients. Covid-19 data showed that CHD hallmarks namely, <jats:italic>Hypercoagulability, Hypercholesterolemia, Hyperglycemia\/Hyperinsulinemia, Inflammation<\/jats:italic> and <jats:italic>Hypertension<\/jats:italic> have an important effect on disease severity. The pathogenic pathways that Covid-19 activate in CHD were integrated into the CHD model. This fully integrated model presents a visual explanation of the mechanism of interaction between CHD and Covid-19 complications. This includes a detailed integrated explanation of the death spiral as a result of interactions between <jats:italic>Inflammation<\/jats:italic>, endothelial cell injury, <jats:italic>Hypercoagulability<\/jats:italic> and hypoxia. Additionally, the model presents the aggravation of this <jats:italic>death spiral<\/jats:italic> through the other CHD hallmarks namely, <jats:italic>Hyperglycemia\/Hyperinsulinemia, Hypercholesterolemia<\/jats:italic>, and\/or <jats:italic>Hypertension<\/jats:italic>. The resulting model further suggests systematically how the pathogenesis of nine <jats:italic>health factors<\/jats:italic> (stress, exercise, smoking, etc.) and seven <jats:italic>pharmaceutical interventions<\/jats:italic> (statins, salicylates, thrombin inhibitors, etc.) may either aggravate or suppress Covid-19 severity. A strong association between CHD and Covid-19 for all the investigated <jats:italic>health factors<\/jats:italic> and <jats:italic>pharmaceutical interventions<\/jats:italic>, except for \u03b2-blockers, was found. It is further discussed how the proposed model can be extended in future to do computational analysis to help assess the risk of Covid-19 in cardiovascular disease. With insight gained from this study, recommendations are made for future research in potential new pharmacotherapeutics. These recommendations could also be beneficial for cardiovascular disease, which killed five times more people in the past year than Covid-19.<\/jats:p>","DOI":"10.3389\/fcvm.2022.737592","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T05:38:55Z","timestamp":1644989935000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications"],"prefix":"10.3389","volume":"9","author":[{"given":"Albertus A.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward H.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andries G. S.","family":"Gous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","article-title":"COVID-19: the first documented coronavirus pandemic in history","volume":"43","author":"Liu","year":"2020","journal-title":"Biomed J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e7386","DOI":"10.7759\/cureus.7386","article-title":"Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2","volume":"12","author":"Valencia","year":"2020","journal-title":"Cureus."},{"key":"B3","unstructured":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejim.2020.04.043","article-title":"Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data","volume":"76","author":"Martins-Filho","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.7326\/L20-1206","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2139\/ssrn.3586685","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1016\/S2214-109X(20)30264-3","article-title":"Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study","volume":"8","author":"Clark","year":"2020","journal-title":"Lancet Glob Heal."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0238215","article-title":"Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis","volume":"15","author":"Ssentongo","year":"2020","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/clc.23465","article-title":"The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: a pooled analysis","volume":"43","author":"Luo","year":"2020","journal-title":"Clin Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am J Emerg Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"The science underlying COVID-19: implications for the cardiovascular system","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jacbts.2020.04.001","article-title":"The heart in COVID-19: primary target or secondary bystander?","volume":"5","author":"Libby","year":"2020","journal-title":"JACC Basic Transl Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","article-title":"COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies","volume":"5","author":"Atri","year":"2020","journal-title":"JACC Basic to Transl Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","article-title":"COVID-19 autopsies, Oklahoma, USA","volume":"153","author":"Barton","year":"2020","journal-title":"Am J Clin Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B23","unstructured":"A systems engineering approach to coronary heart disease\n            MathewsMJ\n          Philos Mech Eng North West Univ South Africa.2015"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-015-0074-5","article-title":"The mechanisms by which antidepressants may reduce coronary heart disease risk","volume":"15","author":"Mathews","year":"2015","journal-title":"BMC Cardiovasc Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-015-0001-x","article-title":"How do high glycemic load diets influence coronary heart disease?","volume":"12","author":"Mathews","year":"2015","journal-title":"Nutr Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12937-015-0011-6","article-title":"The mechanism by which moderate alcohol consumption influences coronary heart disease","volume":"14","author":"Mathews","year":"2015","journal-title":"Nutr J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12903-016-0316-7","article-title":"Oral health and coronary heart disease","volume":"16","author":"Mathews","year":"2016","journal-title":"BMC Oral Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5830\/CVJA-2016-058","article-title":"The integrated effect of moderate exercise on coronary heart disease","volume":"28","author":"Mathews","year":"2017","journal-title":"Cardiovasc J Afr."},{"key":"B29","first-page":"197","article-title":"Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation: in vitro effect of Cerivastatin","volume":"3","author":"Puccetti","year":"1999","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/00005344-199200208-00007","article-title":"Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome","volume":"20","author":"Andersen","year":"1992","journal-title":"J Cardiovasc Pharmacol."},{"key":"B31","unstructured":"Hypercholesterolemia induces vascular cell dysfunction: molecular basis for atherosclerosis19\n            TjadenK\n            PardaliE\n            WaltenbergerJ\n          Austin J Vasc Med.22015"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/jcm9061909","article-title":"Cholesterol in relation to COVID-19: should we care about it?","volume":"9","author":"Radenkovic","year":"2020","journal-title":"J Clin Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.65962","article-title":"Sars-cov-2 requires cholesterol for viral entry and pathological syncytia formation","volume":"10","author":"Sanders","year":"2021","journal-title":"Elife."},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1101\/2020.05.09.086249","article-title":"The role of high cholesterol in age-related COVID19 lethality","volume-title":"bioRxiv [Preprint].","author":"Wang","year":"2020"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104949","article-title":"Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19\u2013systematic review, meta-analysis, and meta-regression","volume":"29","author":"Pranata","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV\u22122 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","article-title":"Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?","volume":"56","author":"Huertas","year":"2020","journal-title":"Eur Respir J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","article-title":"Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade","volume":"21","author":"Dandona","year":"2007","journal-title":"J Hum Hypertens."},{"key":"B39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br J Haematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B45","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The role of inflammatory cytokines in endothelial dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Leo","year":"2020","journal-title":"Circulation."},{"key":"B47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1146\/annurev-biochem-060815-014442","article-title":"Reactive oxygen species and neutrophil function","volume":"85","author":"Winterbourn","year":"2016","journal-title":"Annu Rev Biochem."},{"key":"B48","first-page":"669","article-title":"Role of cytokines as a double-edged sword in sepsis","volume":"27","author":"Chaudhry","year":"2015","journal-title":"In Vivo."},{"key":"B49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0970-2113.197116","article-title":"Mechanisms of hypoxemia","volume":"34","author":"Sarkar","year":"2017","journal-title":"Lung India."},{"key":"B50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/thoraxjnl-2015-207461","article-title":"The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities","volume":"71","author":"Millar","year":"2016","journal-title":"Thorax."},{"key":"B51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.redox.2015.08.016","article-title":"Reactive oxygen species, nutrition, hypoxia and diseases: problems solved?","volume":"6","author":"G\u00f6rlach","year":"2015","journal-title":"Redox Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-021-03469-w","article-title":"High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure","volume":"25","author":"Mellado-Artigas","year":"2021","journal-title":"Crit Care."},{"key":"B56","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19 \u2014 preliminary report","volume":"384","year":"2020","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.561674","article-title":"Celebrex adjuvant therapy on coronavirus disease 2019: an experimental study","volume":"11","author":"Hong","year":"2020","journal-title":"Front Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1213\/ANE.0000000000005292","article-title":"Aspirin use is associated with decreased mechanical ventilation, ICU admission, and in-hospital mortality in hospitalized patients with COVID-19","volume":"132","author":"Chow","year":"2021","journal-title":"Anesth Analg."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1097\/01.mcp.0000174246.15386.69","article-title":"Age is a major risk factor of venous thromboembolism (VTE)","volume":"38","author":"Bizien","year":"2011","journal-title":"Eur Respir J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e044640","DOI":"10.1136\/bmjopen-2020-044640","article-title":"Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies","volume":"11","author":"Pijls","year":"2021","journal-title":"BMJ Open."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/jth.12678","article-title":"Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment","volume":"12","author":"Roach","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1538-7836.2011.04443.x","article-title":"Racial differences in venous thromboembolism","volume":"9","author":"Zakai","year":"2011","journal-title":"J Thromb Haemost."},{"key":"B63","doi-asserted-by":"publisher","first-page":"100455","DOI":"10.1016\/j.eclinm.2020.100455","article-title":"The association of race and COVID-19 mortality","volume":"25","author":"Golestaneh","year":"2020","journal-title":"EClinicalMedicine."},{"key":"B64","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/ATVBAHA.119.313658","article-title":"Genetically determined ABO blood group and its associations with health and disease","volume":"40","author":"Groot","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"104485","DOI":"10.1016\/j.meegid.2020.104485","article-title":"Association between ABO blood groups and COVID-19 infection, severity and demise: a systematic review and meta-analysis","volume":"84","author":"Wu","year":"2020","journal-title":"Infect Genet Evol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12884-021-03772-y","article-title":"The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis","volume":"21","author":"Qeadan","year":"2021","journal-title":"BMC Pregn Childbirth."},{"key":"B68","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1093\/cid\/ciaa1473","article-title":"Relationship between ABO blood groups and coronavirus disease 2019: study design matters","volume":"72","author":"Boudin","year":"2021","journal-title":"Clin Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.dsx.2020.07.005","article-title":"Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: a systematic review","volume":"14","author":"Zaki","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40001-020-00464-9","article-title":"Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis","volume":"25","author":"Chu","year":"2020","journal-title":"Eur J Med Res."},{"key":"B72","first-page":"2","article-title":"Obesity and risk of hypercholesterolemia in Iranian northern adults","volume":"9","author":"Veghari","year":"2013","journal-title":"ARYA Atheroscler."},{"key":"B73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/2229-516X.157150","article-title":"The association between abdominal obesity and serum cholesterol level","volume":"5","author":"Veghari","year":"2015","journal-title":"Int J Appl Basic Med Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","article-title":"Hypolipidemia is associated with the severity of COVID-19","volume":"14","author":"Wei","year":"2020","journal-title":"J Clin Lipidol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1007\/s00125-020-05209-1","article-title":"Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study","volume":"63","author":"Wang","year":"2020","journal-title":"Diabetologia."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjdrc-2020-001476","article-title":"Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study","volume":"8","author":"Wu","year":"2020","journal-title":"BMJ Open Diabetes Res Care."},{"key":"B77","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.2337\/dc11-s239","article-title":"Endothelial dysfunction in diabetes: the role of reparatory mechanisms","volume":"34","author":"Avogaro","year":"2011","journal-title":"Diabetes Care."},{"key":"B78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","article-title":"Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes","volume":"53","author":"Loomans","year":"2004","journal-title":"Diabetes."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/gerona\/glt033","article-title":"Exposure to high or low glucose levels accelerates the appearance of markers of endothelial cell senescence and induces dysregulation of nitric oxide synthase","volume":"68","author":"Rogers","year":"2013","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.jinf.2020.03.059","article-title":"Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis Dear","volume":"81","author":"Zuin","year":"2020","journal-title":"J Infect."},{"key":"B82","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/jch.12546","article-title":"Endothelial function in hypertension: victim or culprit?","volume":"17","author":"Bleakley","year":"2015","journal-title":"J Clin Hypertens."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature: molecular and cellular mechanisms","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension."},{"key":"B84","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.110.010710","article-title":"Dose-response between physical activity and risk of coronary heart disease: a meta-analysis","volume":"124","author":"Sattelmair","year":"2011","journal-title":"Circulation."},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1007\/s10389-020-01468-9","article-title":"Relationship between physical activity, healthy lifestyle and COVID-19 disease severity; a cross-sectional study","volume-title":"Z Gesundh Wiss.","author":"Tavakol","year":"2021"},{"key":"B86","doi-asserted-by":"publisher","first-page":"j5855","DOI":"10.1136\/bmj.j5855","article-title":"Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports","volume":"360","author":"Hackshaw","year":"2018","journal-title":"BMJ."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/jmv.26389","article-title":"The effect of smoking on COVID-19 symptom severity: systematic review and meta-analysis","volume":"93","author":"Reddy","year":"2020","journal-title":"J Med Virol."},{"key":"B88","first-page":"197","article-title":"Periodontal diseases and cardiovascular events: meta-analysis of observational studies","volume":"59","author":"Blaizot","year":"2009","journal-title":"Int Dent J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/jcpe.13435","article-title":"Association between periodontitis and severity of COVID-19 infection: a case\u2013control study","volume":"48","author":"Marouf","year":"2021","journal-title":"J Clin Periodontol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","article-title":"Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Rosengren","year":"2004","journal-title":"Lancet."},{"key":"B91","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","article-title":"Association between high serum total cortisol concentrations and mortality from COVID-19","volume":"8","author":"Tant","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1093\/eurheartj\/ehl338","article-title":"Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies","volume":"27","author":"Nicholson","year":"2006","journal-title":"Eur Heart J."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S2666-7568(20)30013-1","article-title":"Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis","volume":"1","author":"Yang","year":"2020","journal-title":"Lancet Heal Longev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11325-009-0298-7","article-title":"Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death","volume":"14","author":"Shah","year":"2010","journal-title":"Sleep Breath."},{"key":"B95","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmjresp-2020-000845","article-title":"Sleep apnoea is a risk factor for severe COVID-19","volume":"8","author":"Strausz","year":"2021","journal-title":"BMJ Open Respir Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/2047487312460020","article-title":"Insomnia and risk of cardiovascular disease: a meta-analysis","volume":"21","author":"Sofi","year":"2014","journal-title":"Eur J Prev Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/bmjnph-2021-000228","article-title":"COVID-19 illness in relation to sleep and burnout","volume":"4","author":"Kim","year":"2021","journal-title":"BMJ Nutr Prev Heal."},{"key":"B98","doi-asserted-by":"publisher","first-page":"d671","DOI":"10.1136\/bmj.d671","article-title":"Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis","volume":"342","author":"Ronksley","year":"2011","journal-title":"BMJ."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.amjcard.2012.01.385","article-title":"Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease","volume":"109","author":"Dong","year":"2012","journal-title":"Am J Cardiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Collins","year":"2009","journal-title":"Lancet."},{"key":"B103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B105","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(03)14287-0","article-title":"Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial","volume":"362","author":"Wallentin","year":"2003","journal-title":"Lancet."},{"key":"B106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/joim.13205","article-title":"Direct oral anticoagulant use and risk of severe COVID-19","volume":"289","author":"Flam","year":"2021","journal-title":"J Intern Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/01.HYP.0000174591.42889.a2","article-title":"Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention","volume":"46","author":"Verdecchia","year":"2005","journal-title":"Hypertension."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart."},{"key":"B109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2012.10.011","article-title":"A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure","volume":"61","author":"Savarese","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur Heart J."},{"key":"B111","first-page":"284","article-title":"A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure","volume":"67","author":"De Peuter","year":"2009","journal-title":"Neth J Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jjcc.2020.10.015","article-title":"Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis","volume":"77","author":"Ren","year":"2021","journal-title":"J Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health Outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"J Am Med Assoc."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","article-title":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review","volume":"168","author":"Selvin","year":"2008","journal-title":"Arch Intern Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2213-8587(21)00050-4","article-title":"Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England","volume":"8587","author":"Khunti","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.amjmed.2010.11.015","article-title":"Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients","volume":"124","author":"Scherrer","year":"2011","journal-title":"Am J Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical Trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/bjsports-2021-104080","article-title":"Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: a study in 48 440 adult patients","volume":"55","author":"Sallis","year":"2021","journal-title":"Br J Sports Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jshs.2018.09.009","article-title":"The compelling link between physical activity and the body's defense system","volume":"8","author":"Nieman","year":"2019","journal-title":"J Sport Heal Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/0140-6736(92)90730-Q","article-title":"Insulin resistance and cigarette smoking","volume":"339","author":"Facchini","year":"1992","journal-title":"Lancet."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0735-1097(02)02982-0","article-title":"Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?","volume":"41","author":"Reaven","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ypmed.2007.07.001","article-title":"Smoking status and adiponectin in healthy Japanese men and women","volume":"45","author":"Takefuji","year":"2007","journal-title":"Prev Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/jc.2006-2155","article-title":"The relationship between smoking status and cortisol secretion","volume":"92","author":"Badrick","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B124","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/bmj.298.6676.784","article-title":"Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data","volume":"298","author":"Craig","year":"1989","journal-title":"BMJ."},{"key":"B125","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0022034511421200","article-title":"Cigarette smoking and inflammation: cellular and molecular mechanisms","volume":"91","author":"Lee","year":"2012","journal-title":"J Dent Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/ATVBAHA.109.195024","article-title":"Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation","volume":"30","author":"Barua","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1128\/IAI.66.11.5337-5343.1998","article-title":"Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis","volume":"66","author":"Deshpande","year":"1998","journal-title":"Infect Immun."},{"key":"B128","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1101\/2020.07.09.20149369","article-title":"Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank","volume":"36","author":"Fan","year":"2021","journal-title":"Eur J Epidemiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03079-y","article-title":"VEGF-D: a novel biomarker for detection of COVID-19 progression","volume":"24","author":"Kong","year":"2020","journal-title":"Crit Care."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-020-00230-x","article-title":"IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19","volume":"26","author":"Chen","year":"2020","journal-title":"Mol Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.3398","article-title":"Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes","volume":"2019","author":"Merzon","year":"2020","journal-title":"Diabetes Metab Res Rev."},{"key":"B132","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/add.15194","article-title":"Alcohol: a probable risk factor of COVID-19 severity","volume":"116","author":"Saengow","year":"2021","journal-title":"Addiction."},{"key":"B133","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.chest.2017.11.041","article-title":"The effect of alcohol consumption on the risk of ARDS: a systematic review and meta-analysis","volume":"154","author":"Simou","year":"2018","journal-title":"Chest."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2020.108614","article-title":"Laboratory biomarkers associated with COVID-19 severity and management","volume":"221","author":"Keddie","year":"2020","journal-title":"Clin Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/bmjebm-2020-111536","article-title":"Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis","volume":"26","author":"Malik","year":"2020","journal-title":"BMJ Evidence-Based Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Jalali Nadoushan","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e23315","DOI":"10.1097\/MD.0000000000023315","article-title":"Association of elevated inflammatory markers and severe COVID-19: a meta-analysis","volume":"99","author":"Ji","year":"2020","journal-title":"Medicine."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the Heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","article-title":"Characterization of the Inflammatory Response to Severe COVID-19 Illness","volume":"202","author":"Mcelvaney","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/j.jinf.2020.08.010","article-title":"Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: a case series","volume":"82","author":"Luis Garc\u00eda de Guadiana","year":"2020","journal-title":"J Infect."},{"key":"B141","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.jhh.1002001","article-title":"Statins: another class of antihypertensive agents?","volume":"20","author":"Milionis","year":"2006","journal-title":"J Hum Hypertens."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)01828-9","article-title":"Anti-inflammatory effects of aspirin and sodium salicylate","volume":"447","author":"Amann","year":"2002","journal-title":"Eur J Pharmacol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas","year":"2007","journal-title":"Blood."},{"key":"B144","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.thromres.2006.10.026","article-title":"The anti-inflammatory effects of heparin and related compounds","volume":"122","author":"Young","year":"2008","journal-title":"Thromb Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19 \u2013a vascular disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00277-020-04138-8","article-title":"COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure","volume":"99","author":"Marchetti","year":"2020","journal-title":"Ann Hematol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1021\/acsptsci.0c00219","article-title":"SARS-CoV-2, hypoxia, and calcium signaling: the consequences and therapeutic options","volume":"4","author":"Danta","year":"2021","journal-title":"ACS Pharmacol Transl Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-020-00263-3","article-title":"Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm","volume":"17","author":"Jahani","year":"2020","journal-title":"J Inflamm."},{"key":"B149","doi-asserted-by":"publisher","first-page":"115294","DOI":"10.1016\/j.applthermaleng.2020.115294","article-title":"A simulation-based prediction model for coal-fired power plant condenser maintenance","volume":"174","author":"Mathews","year":"2020","journal-title":"Appl Therm Eng."},{"key":"B150","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun Biol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.21873\/invivo.12134","article-title":"Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2","volume":"34","author":"Lehrer","year":"2020","journal-title":"In Vivo."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-73308\/v1","article-title":"Ivermectin as a promising RNA-dependent RNA polymerase inhibitor and a therapeutic drug against SARS-CoV2: evidence from in silico studies","author":"Swargiary","year":"2020","journal-title":"Res Sq. [Preprint]"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1097\/MJT.0000000000001377","article-title":"Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19","volume":"28","author":"Kory","year":"2021","journal-title":"Am J Ther."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.31219\/osf.io\/k37ft","article-title":"Ivermectin for prevention and treatment of COVID-19 infection: a systematic review and meta-analysis","volume":"27","author":"Bryant","year":"2021","journal-title":"Am J Ther."},{"key":"B156","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/00034983.1992.11812667","article-title":"Coagulation abnormalities and ivermectin","volume":"86","author":"Whitworth","year":"1992","journal-title":"Ann Trop Med Parasitol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms2924","article-title":"The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism","volume":"4","author":"Jin","year":"2013","journal-title":"Nat Commun."},{"key":"B158","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1472-8206.2009.00684.x","article-title":"Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway","volume":"23","author":"Ci","year":"2009","journal-title":"Fundam Clin Pharmacol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e001350","DOI":"10.1136\/openhrt-2020-001350","article-title":"Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19","volume":"7","author":"DiNicolantonio","year":"2020","journal-title":"Open Hear."},{"key":"B160","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.3748\/wjg.v27.i26.3951","article-title":"Liver dysfunction and SARS-CoV-2 infection","volume":"27","author":"Gracia-Ramos","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B161","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000001377","article-title":"Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19","volume-title":"Front Pharmacol.","author":"Kory","year":"2021"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.737592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T05:39:06Z","timestamp":1644989946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.737592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":162,"alternative-id":["10.3389\/fcvm.2022.737592"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.737592","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"article-number":"737592"}}